Evidence map›Paper›PMID 40673578›Full record

ArticleJournal of the American Heart Association2025

Endothelial Activation and Stress Index Is Associated With Adverse Maternal and Perinatal Outcomes in Preeclampsia.

Anna S Scholz, Annabel Kussner, Michael Elsässer, Thomas Luft, Stephanie Wallwiener, Alexandra von Au

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna S ScholzDepartment of Gynecology and Obstetrics University Hospital Heidelberg Heidelberg Germany.ORCID 0000-0002-3439-3872
Annabel KussnerDepartment of Gynecology and Obstetrics University Hospital Heidelberg Heidelberg Germany.
Michael ElsässerDepartment of Gynecology and Obstetrics University Hospital Heidelberg Heidelberg Germany.
Thomas LuftDepartment of Internal Medicine V, Hematology, Oncology and Rheumatology University Hospital Heidelberg Heidelberg Germany.ORCID 0000-0002-0387-1640
Stephanie WallwienerDepartment of Obstetrics and Fetal Medicine University Hospital Halle (Saale) Halle Germany.
Alexandra von AuDepartment of Gynecology and Obstetrics University Hospital Heidelberg Heidelberg Germany.ORCID 0000-0001-7649-4914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndothelial dysfunction represents a key driver in the development of preeclampsia. The Endothelial Activation and Stress Index (EASIX) is a validated predictor of endothelial-related complications in diverse clinical settings beyond obstetrics. Therefore, we aimed to assess the predictive performance of EASIX for adverse maternal and perinatal outcomes in pregnancies with preeclampsia.

methodsThis retrospective study analyzed data from 986 patients with preeclampsia who delivered at Heidelberg University Hospital between 2017 and 2022. The primary end points were adverse maternal (death; kidney failure; pulmonary edema; eclampsia; disseminated intravascular coagulation; hemorrhage; cerebrovascular event; and hemolysis, elevated liver enzymes, low platelets syndrome); and perinatal events (death, stillbirth, preterm delivery, placental abruption, respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis). EASIX was calculated as a product of lactate dehydrogenase and creatinine, both divided by platelet counts.

resultsFive hundred forty-two patients were eligible for the analysis. EASIX was significantly elevated in patients with a maternal adverse event (1.41±0.86 versus 0.87±0.5,

conclusionsOur findings underline EASIX as an easily available predictive marker of the risk of maternal and perinatal adverse outcomes in patients with preeclampsia. We propose that EASIX may be useful to stratify the individual risk of adverse events, especially in patients with early-onset preeclampsia.

Indexed as

Endothelium, VascularPre-EclampsiaAdultBiomarkersFemaleHumansInfant, NewbornPredictive Value of TestsPregnancyPregnancy OutcomeRetrospective StudiesRisk AssessmentRisk FactorsBiomarkersadverse maternal outcomeadverse perinatal outcomeendothelial dysfunctionpredictionpreeclampsia

Identifiers

PMID40673578
PMCPMC12449954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.